Condom Express.com Condom Express.com VIEW THE CONTENTS OF YOUR BASKET  AND CHECKOUT View / Check Out!
Customer Service
Product Info
Track Order
Order Info
CONDOMS LUBRICANTS SEX TOYS LINGERIE NOVELTIES

 
Product List:
Order By Phone

CONDOMS BY BRAND
Amore Condoms
Avanti Condoms
Beyond 7 Condoms
Crown Condoms
Contempo Condoms
Durex Condoms
Female Condoms
Glow in the Dark
Inspiral Condoms
Kimono Condoms
Lifestyles Condoms
Natural Lamb Condoms
Okamoto Condoms
Pleasure Plus Condoms
Premium Condoms
Paradise Condoms
Supra Condoms
Trojan Condoms
Trustex Condoms
Condom Sample Packs

CONDOMS BY TYPE
Custom Imprinted
Polyurethane Condoms
Extra Thin Condoms
Extra Sensitive Condoms
Ribbed Condoms
Dots
Ribs & Dots
Extra Head Room
Non-Lubricated Condoms
Lubricated Condoms
Tight Fitting Condoms
Loose Fitting Condoms
Extra Large Condoms
Extra Strength Condoms
Flavored Condoms
W/Spermicide
W/O Spermicide
Colors
Lamb Skins

CUSTOMER SERVICE
F.A.Q.'S
Contact us by Mail
Contact us by E-Mail
Contact us by Phone
General Information
Question About an Order?

SECURITY
Your Privacy
Secure on-line Ordering

CONDOM INFO.
All About Condoms
Tips On Using Condoms
Important Phone #'s
How To Use A Condom

Condom Express Newsletter
Stay informed about
New Products, Discounts, Specials and Condom News
Enter Your E-mail Address



Affiliate Program
Sell Condoms, Lubricants, Sex Toys and more from your website.
 


Below is a letter from the Centers for Disease Control on the use of the spermicide nonoxynol-9 (N- 9),
It states quite clearly that nonoxynol-9 should not be recommended as a preventive measure against HIV




DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Services

Centers for Disease Control
and Prevention (CDC)
Atlanta, Ga30333

August 4 2000

Dear Colleague:

At the International AIDS Conference held in Durban, South Africa, from July 9.14, 2000, researchers with the Joint United Nations Program on AIDS (UNAIDS) presented results of an important study about HIV prevention in woman. They studied a product widely used in spermicides, nonoxynol-9 (N- 9), to determine if it would be Effective in preventing HIV transmission. Products designed to provide a chemical barrier to HIV and STD transmission are called microbicides. This notice summarizes the study results and some implications for use of this product in prevention programs.

From 1996 until May 2000, UNAIDS sponsored a study of the effectiveness of a gel which contained 52.5 milligrams of N-9 (called COL'1492 in the trial and Advantag-S in the United States), compared to an inactive placebo gel. The study was conducted in several locations in Africa. Nearly 1,000 HIV-negative commercial sex workers were enrolled in the trial, and all women were counseled to use condoms consistently and correctly. In addition to condom use, the women were asked to use a vaginal gel each time they had intercourse. Half of the women were provided a placebo gel and half of the women received an N-9 gel. None of the woman, or the researchers, knew which product each woman received, and all of the women were informed of the possible risks, benefits, arid unknowns involved in the study.

At the end of the trial, researchers found that the women who used N-9 gel had become infected with HIV at about a 50% higher rate than women who used the placebo gel. Further, the more frequently women used only N-9 gel (without a condom) to protect themselves, the higher their risk of becoming infected. Simply stated, N-9 did not protect against HIV infection and may have caused more transmission. Women who used N-9 also had more vaginal lesions, which might have facilitated HIV transmission.

This study was conducted among women at very high risk commercial sex workers who used a great deal of the product on a frequent basis. The adverse effects might not be seen at the same level among women who are using spermicides with N.9 less frequently or in different formulations. However, given that N-9 has now been proven ineffective against HIV transmission, the possibility of risk, with no benefit, indicates that N-9 should not be recommended as an effective means of HIV prevention.

With the release of these data, the scientific evidence on N-9 as an HIV prevention strategy is now conclusive and significant. As a result prevention guidelines must be re-evaluated UNAIDS and CDC will be holding consultations over the next few months to consider official revisions to public health guidelines for the use of N-9 for HIV prevention and for pregnancy prevention in populations at high risk for HIV. In the interim, those findings have several immediate implications.

First, any community delivering hierarchical prevention messages that counsel individuals who can't use a condom to consider spermicides with N.9 for HIV prevention should immediately revise these messages. This study suggests that the use of N-9 for HIV prevention may he harmful. Second, anyone currently using N- 9 as a microbicide to protect themselves from HIV transmission during anal intercourse should be informed of the ineffectiveness of this agent and warned of the potential risk of this practice.

CDC has never recommended N-9 alone for HIV prevention, but current recommendations do emphasize the consistent and correct use of condoms, with or without a spermicide. While the level of N-9 used as a lubricant in condoms is much lower than the level found to be harmful in this study, CDC will re-evaluate this guidance as part of the upcoming consultation. In the interim, while N-9 will not offer any additional protection against HIV, a condom lubricated with N- 9 is clearly better than using no condom at all. The protection provided by the condom against HIV far outweighs the potential risk of N-9. If given the choice, condoms without N-9 may be a better option for HIV prevention.

From a research perspective, these findings point to the need for accelerated efforts to identify a safe and effective microbicide. Of the more than 7,000 new HIV infections occurring in the world each day, about 90% are the result of heterosexual transmission. In addition, more than 330 million new cases of other STDs, such as gonorrhea, chlamydia, and syphilis, occur each year.

For those who are unable to access condoms or to negotiate their use, there is an urgent need to identify an effective alternative to prevent HIV and STD transmission. Moving forward with the evaluation of microbicide candidates, which are not likely to cause the same negative effect seen with N-9, should be a public health priority.

We appreciate any assistance you can provide in disseminating this critical public health information and will keep you informed as the consultations are completed

Sincerely,


Helene D. Gayle, M.D., M.P.H.
Director, National Center for HIV, STD, and TB Prevention
Centers for Disease Control and Prevention




Products

Condoms
Lubricants
Novelties
Vibrating Rings
Condom Vending
Oral Dams
Gifts
Kama Sutra
Condom Cases
Imprinted Condoms
Sex Toys
Lingerie
.
.
.
.
.
.
.
.
.
.
.
Information

All About Condoms
Tips On Using Condoms
Important Phone #'s
How To Use A Condom
F.A.Q.'S
.
.
.
.
.
.
.
.
.
.
.
Customer Service

Shipping Rates
Contact us by Mail
Contact us by E-Mail
Contact us by Phone
General Information
Question About an Order?
Your Privacy

2257 Compliance Statement
Questions? Click Here to Send a Message to Customer Service

Condoms Express & Condoms of the Month Club
are trade marks of Jay-Roc Marketing Inc.
Serving Customers on the Internet Since 1994

Live operators 24 hours per day 7 days a week
Customer Service # 1-888-773-9869, or (513) 618-1875
# Tell the operator your priority service code is: CONDOM

Content : 1994-2008 Jay-Roc Marketing Inc.. All Rights Reserved. E&OE.